A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy

NCT ID: NCT05707377

This clinical trial is studying a medication called zanubrutinib to see how safe and effective it is for treating a kidney condition known as primary membranous nephropathy. The trial is divided in...

Recruiting

Phase: PHASE2 Conditions: Primary Membranous Nephropathy

A Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Inhaled H057 in the Treatment of Acute Exacerbations of Bronchiectasis

NCT ID: NCT06958861

This clinical trial is testing a new inhaled medication called H057 to see how well it works and how safe it is for treating acute exacerbations of bronchiectasis. Bronchiectasis is a lung conditio...

Not yet recruiting

Phase: PHASE2 Conditions: Acute Exacerbations of Bronchiectasis

Regular Physical Activity in Patients With Symptomatic Intracranial Arterial Stenosis

NCT ID: NCT06615726

This clinical trial is studying whether regular physical activity can help prevent strokes in patients who have symptoms from a narrowing of the arteries in the brain, known as symptomatic intracra...

Recruiting

Phase: PHASE3 Conditions: Ischemic Stroke, Transient Ischemic Attack

Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients

NCT ID: NCT06315231

This clinical trial is studying a new treatment called edaravone dexborneol sublingual tablets to see if it can help improve thinking and memory problems (known as post-stroke cognitive impairment)...

Recruiting

Phase: PHASE2 Conditions: Post-stroke Cognitive Impairment

Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5

NCT ID: NCT06196320

This clinical trial, called the Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5, is studying a treatment for patients who have had an ischemic stroke caused by a blocka...

Recruiting

Phase: PHASE3 Conditions: Ischemic Stroke, Acute

Efficacy and Safety of SR1375 in Adult Patients With CAP

NCT ID: NCT06577558

This clinical trial is studying a new medication called SR1375 to see how well it works and how safe it is for adult patients who have community-acquired pneumonia (CAP). Community-acquired pneumon...

Recruiting

Phase: PHASE2 Conditions: Community-acquired Pneumonia

China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)

NCT ID: NCT04974138

The China Stroke Primary Prevention Trial 2 (CSPPT2-CC/CT) is studying whether a combination of a blood pressure medication called amlodipine and folic acid can help prevent strokes in people with ...

Recruiting

Phase: PHASE4 Conditions: Hypertension, Insufficient Plasma Folate Levels (<12ng/mL) +2 more

China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype

NCT ID: NCT04974151

The China Stroke Primary Prevention Trial 2 is studying the best way to prevent strokes in people who have high blood pressure (hypertension) and a specific genetic marker called the MTHFR 677 TT g...

Recruiting

Phase: PHASE4 Conditions: Hypertension, MTHFR 677 TT Genotype

China Liver Cancer Clinical Registry Cohort Database

NCT ID: NCT06777485

The China Liver Cancer Clinical Registry Cohort Database is a study designed to gather important information about patients with liver cancer. The goal is to create a reliable database that helps r...

Recruiting

Conditions: Liver Cancer

A Clinical Trial Evaluating TQB2102 for Injection in Combination With Behmosubaisumab/Payamprolizumab With or Without Chemotherapy in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma

NCT ID: NCT06767800

This clinical trial is looking at a new treatment called TQB2102, which is being tested for patients with a specific type of cancer known as HER2-positive gastroesophageal adenocarcinoma. This type...

Not yet recruiting

Phase: PHASE2 Conditions: Gastroesophageal Adenocarcinoma

Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma

NCT ID: NCT06664021

This clinical trial is investigating a new treatment approach for patients with high-risk intrahepatic cholangiocarcinoma, a type of cancer that starts in the bile ducts inside the liver, after the...

Recruiting

Phase: PHASE2 Conditions: Intrahepatic Cholangiocarcinoma

Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Destined to Undergo Elective Invasive Surgery

NCT ID: NCT06673498

This clinical trial is studying a combination treatment of two medications, lusutrombopag and recombinant human thrombopoietin, to see if they can help patients with low platelet counts (thrombocyt...

Recruiting

Phase: PHASE2 Conditions: Thrombocytopenia

A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer

NCT ID: NCT06431490

This clinical trial is studying a new treatment called TQB2102 for patients with a specific type of cancer known as HER2-positive biliary tract cancer. The purpose of the trial is to see how effect...

Recruiting

Phase: PHASE1 Conditions: Biliary Tract Cancer

Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab

NCT ID: NCT06498622

This clinical trial is studying a new treatment combination of two medications, donafenib and envafolimab, for patients who have a high risk of their liver cancer (specifically hepatocellular carci...

Recruiting

Phase: PHASE2 Conditions: Hepatocellular Carcinoma

Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion

NCT ID: NCT06155032

This clinical trial is investigating whether adding a treatment called endovascular therapy (EVT) to the best medical management can help patients who have experienced a minor stroke with a specifi...

Recruiting

Phase: NA Conditions: Stroke, Ischemic, Cerebrovascular; Disorder, Occlusive

Local Liver Treatment for Multi-organ Colorectal Cancer Metastases

NCT ID: NCT06449937

This clinical trial is looking at how well local treatments for liver tumors can work when combined with other treatments for colorectal cancer that has spread to multiple organs. The goal is to se...

Recruiting

Phase: NA Conditions: Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver +1 more

A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.

NCT ID: NCT06010901

This clinical trial is studying a new treatment for advanced colorectal cancer, specifically looking at a medication called TQB2618. The trial will explore how well TQB2618 works on its own and whe...

Recruiting

Phase: PHASE1 Conditions: Colorectal Cancer

Main Menu

Clinical Trials in Fuyang, Anhui

17 Active Trials Found in Fuyang

A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy

A Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Inhaled H057 in the Treatment of Acute Exacerbations of Bronchiectasis

Regular Physical Activity in Patients With Symptomatic Intracranial Arterial Stenosis

Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients

Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5

Efficacy and Safety of SR1375 in Adult Patients With CAP

China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)

China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype

China Liver Cancer Clinical Registry Cohort Database

A Clinical Trial Evaluating TQB2102 for Injection in Combination With Behmosubaisumab/Payamprolizumab With or Without Chemotherapy in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma

Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma

Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Destined to Undergo Elective Invasive Surgery

A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer

Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab

Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion

Local Liver Treatment for Multi-organ Colorectal Cancer Metastases

A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.